IBL HealthCare Statistics

Total Valuation

IBL HealthCare has a market cap or net worth of PKR 3.02 billion. The enterprise value is 3.38 billion.

Market Cap	3.02B
Enterprise Value	3.38B

Important Dates

The last earnings date was Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	n/a

Share Statistics

IBL HealthCare has 85.67 million shares outstanding. The number of shares has decreased by -0.28% in one year.

Current Share Class	85.67M
Shares Outstanding	85.67M
Shares Change (YoY)	-0.28%
Shares Change (QoQ)	+0.91%
Owned by Insiders (%)	1.16%
Owned by Institutions (%)	4.42%
Float	21.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.85
PB Ratio	1.34
P/TBV Ratio	1.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.99, with an EV/FCF ratio of -15.91.

EV / Earnings	-86.74
EV / Sales	0.95
EV / EBITDA	23.99
EV / EBIT	24.90
EV / FCF	-15.91

Financial Position

The company has a current ratio of 2.17, with a Debt / Equity ratio of 0.17.

Current Ratio	2.17
Quick Ratio	1.29
Debt / Equity	0.17
Debt / EBITDA	2.78
Debt / FCF	-1.84
Interest Coverage	2.26

Financial Efficiency

Return on equity (ROE) is -1.72% and return on invested capital (ROIC) is 3.29%.

Return on Equity (ROE)	-1.72%
Return on Assets (ROA)	2.35%
Return on Invested Capital (ROIC)	3.29%
Return on Capital Employed (ROCE)	5.98%
Revenue Per Employee	12.21M
Profits Per Employee	-133,414
Employee Count	292
Asset Turnover	0.99
Inventory Turnover	2.83

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.44% in the last 52 weeks. The beta is 0.70, so IBL HealthCare's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	-16.44%
50-Day Moving Average	36.51
200-Day Moving Average	35.90
Relative Strength Index (RSI)	39.27
Average Volume (20 Days)	217,844

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, IBL HealthCare had revenue of PKR 3.57 billion and -38.96 million in losses. Loss per share was -0.46.

Revenue	3.57B
Gross Profit	830.57M
Operating Income	135.70M
Pretax Income	62.01M
Net Income	-38.96M
EBITDA	137.97M
EBIT	135.70M
Loss Per Share	-0.46

Full Income Statement

Balance Sheet

The company has 31.04 million in cash and 391.12 million in debt, giving a net cash position of -360.09 million or -4.20 per share.

Cash & Cash Equivalents	31.04M
Total Debt	391.12M
Net Cash	-360.09M
Net Cash Per Share	-4.20
Equity (Book Value)	2.25B
Book Value Per Share	26.26
Working Capital	1.62B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -194.03 million and capital expenditures -18.34 million, giving a free cash flow of -212.36 million.

Operating Cash Flow	-194.03M
Capital Expenditures	-18.34M
Free Cash Flow	-212.36M
FCF Per Share	-2.48

Full Cash Flow Statement

Margins

Gross margin is 23.29%, with operating and profit margins of 3.81% and -1.09%.

Gross Margin	23.29%
Operating Margin	3.81%
Pretax Margin	1.74%
Profit Margin	-1.09%
EBITDA Margin	3.87%
EBIT Margin	3.81%
FCF Margin	n/a

Dividends & Yields

IBL HealthCare does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.28%
Shareholder Yield	0.28%
Earnings Yield	-1.29%
FCF Yield	-7.03%

Dividend Details

Stock Splits

The last stock split was on October 19, 2023. It was a forward split with a ratio of 1.2.

Last Split Date	Oct 19, 2023
Split Type	Forward
Split Ratio	1.2

Scores

IBL HealthCare has an Altman Z-Score of 3.39.

Altman Z-Score	3.39
Piotroski F-Score	n/a